Similarly, after adjusting for income quintile, grade, ERBB2 status, and age, ER-negative cancers had significantly higher odds than ER-positive cancers of being interval compared with screen-detected cancers (OR, 2.88; 95% CI, 2.01-4.13). This evidence concerns the gene ERBB2 and cancer.